Literature DB >> 21906575

Hydrodynamic delivery of human IL-15 cDNA increases murine natural killer cell recovery after syngeneic bone marrow transplantation.

Isabel Barao1, Maite Alvarez, Doug Redelman, Jonathan M Weiss, John R Ortaldo, Robert H Wiltrout, William J Murphy.   

Abstract

Immune deficiency immediately following bone marrow transplantation (BMT) increases susceptibility to opportunistic infections as well as tumor relapse. Natural Killer (NK) cells play important roles in the resistance to virally infected and transformed cells. Interleukin (IL)-15 has been shown to be essential for NK cell development and survival. We administered human (h) IL-15 cDNA (pIL-15) via hydrodynamic delivery to murine recipients undergoing congenic BMT to determine its effects on NK cell reconstitution. Hydrodynamic pIL-15 delivery resulted in high levels of hIL-15 protein in the serum that lasted for several days and then quickly declined. The appearance of hIL-15 was followed by a significant increase of mature donor-derived NK cells within the bone marrow, spleens, and livers of the treated recipients. No accumulation of immature NK cell progenitors was observed. The NK cells from IL-15-treated recipients displayed an activated phenotype and were lytically active toward tumor targets in vitro to a similar degree as did those cells from recipients treated with control plasmid. This suggests that the predominant effect of IL-15 was a quantitative increase in total NK cell numbers and not qualitative changes in NK cell functions. No toxicities or adverse effects were observed. Studies performed in transplanted mice bearing renal carcinoma tumors demonstrated that this mode of hIL-15 gene delivery resulted in increased antitumor responses. These results support the use of cytokine gene transfer-based regimens as a platform to augment NK cell recovery after BMT.
Copyright © 2011 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21906575      PMCID: PMC3506429          DOI: 10.1016/j.bbmt.2011.08.023

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  38 in total

Review 1.  Biology of natural killer cells in cancer and infection.

Authors:  Jeffrey S Miller
Journal:  Cancer Invest       Date:  2002       Impact factor: 2.176

Review 2.  Progress in the development of immunotherapy for the treatment of patients with cancer.

Authors:  S A Rosenberg
Journal:  J Intern Med       Date:  2001-12       Impact factor: 8.989

3.  Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2.

Authors:  J S Miller; V McCullar
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

4.  Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease.

Authors:  O Alpdogan; C Schmaltz; S J Muriglan; B J Kappel; M A Perales; J A Rotolo; J A Halm; B E Rich; M R van den Brink
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

5.  Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma.

Authors:  G Q Phan; P Attia; S M Steinberg; D E White; S A Rosenberg
Journal:  J Clin Oncol       Date:  2001-08-01       Impact factor: 44.544

6.  Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2.

Authors:  M Rosenstein; S E Ettinghausen; S A Rosenberg
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

Review 7.  The immunobiology of natural killer cells and bone marrow allograft rejection.

Authors:  Isabel Barao; William J Murphy
Journal:  Biol Blood Marrow Transplant       Date:  2003-12       Impact factor: 5.742

8.  Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.

Authors:  Guanghua Chen; Depei Wu; Yi Wang; Jiannong Cen; Yufeng Feng; Aining Sun; Xiaowen Tang; Huirong Chang; Ziling Zhu
Journal:  Eur J Haematol       Date:  2008-06-28       Impact factor: 2.997

9.  In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells.

Authors:  Megan A Cooper; Jennifer E Bush; Todd A Fehniger; Jeffrey B VanDeusen; Ross E Waite; Yang Liu; Hector L Aguila; Michael A Caligiuri
Journal:  Blood       Date:  2002-07-05       Impact factor: 22.113

10.  Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice.

Authors:  M K Kennedy; M Glaccum; S N Brown; E A Butz; J L Viney; M Embers; N Matsuki; K Charrier; L Sedger; C R Willis; K Brasel; P J Morrissey; K Stocking; J C Schuh; S Joyce; J J Peschon
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

View more
  8 in total

1.  The dynamic impact of hydrodynamic gene transfer on the immune system.

Authors:  Yan Wu; Shoubao Ma; Yonghao Liu; Lei Lei; Bo Hu; Haiyan Liu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells.

Authors:  Erik Ames; Robert J Canter; Steven K Grossenbacher; Stephanie Mac; Rachel C Smith; Arta M Monjazeb; Mingyi Chen; William J Murphy
Journal:  Oncoimmunology       Date:  2015-06-05       Impact factor: 8.110

3.  NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype.

Authors:  Erik Ames; Robert J Canter; Steven K Grossenbacher; Stephanie Mac; Mingyi Chen; Rachel C Smith; Takeshi Hagino; Jessica Perez-Cunningham; Gail D Sckisel; Shiro Urayama; Arta M Monjazeb; Ruben C Fragoso; Thomas J Sayers; William J Murphy
Journal:  J Immunol       Date:  2015-09-11       Impact factor: 5.422

4.  Human fused NKG2D-IL-15 protein controls xenografted human gastric cancer through the recruitment and activation of NK cells.

Authors:  Yan Chen; Bei Chen; Ti Yang; Weiming Xiao; Li Qian; Yanbing Ding; Mingchun Ji; Xiaoqun Ge; Weijuan Gong
Journal:  Cell Mol Immunol       Date:  2015-09-14       Impact factor: 11.530

Review 5.  Positive and negative regulation by NK cells in cancer.

Authors:  Can M Sungur; William J Murphy
Journal:  Crit Rev Oncog       Date:  2014

Review 6.  Translational Advances of Hydrofection by Hydrodynamic Injection.

Authors:  Luis Sendra; María José Herrero; Salvador F Aliño
Journal:  Genes (Basel)       Date:  2018-03-01       Impact factor: 4.096

Review 7.  Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity.

Authors:  Alberto Mendoza-Valderrey; Maite Alvarez; Andrea De Maria; Kim Margolin; Ignacio Melero; Maria Libera Ascierto
Journal:  Cells       Date:  2022-10-06       Impact factor: 7.666

8.  The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses.

Authors:  Isabel Barao
Journal:  Front Immunol       Date:  2013-01-04       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.